In a bid to tackle malaria in Nigeria, a Korean firm, Shin Poong Pharmaceutical Company, has introduced an anti-malaria drug that will reduce the increasing number of malaria-induced ailments among Nigerians to the Nigerian market. The Chief Executive Officer of the company, Wonjune Chang, told journalists at an event to mark the World Malaria Day (WMD) in Abuja that the anti-malaria drug, Pyramax, was produced with  a upgraded chemical composition that had a strong effect on malaria. The Managing Director of Dovizia Pharmaceutical Services, Oladipupo Ojo, said the uniqueness of the drug was that it had chemical contents that attacked malaria within a few hours of administration. The Minister of Health, Prof. Isaac Adewole, who was briefed on the efficacy of the drug at the event, commended the effort of the company on the fight against malaria in the country. He promised that government would continue to support any good cause that has positive impact on Nigeria’s health system.